865 Shares in Axon Enterprise, Inc. (NASDAQ:AXON) Purchased by Bridges Investment Management Inc.

Bridges Investment Management Inc. bought a new stake in shares of Axon Enterprise, Inc. (NASDAQ:AXONFree Report) in the second quarter, according to its most recent Form 13F filing with the SEC. The fund bought 865 shares of the biotechnology company’s stock, valued at approximately $255,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Avantax Advisory Services Inc. raised its holdings in shares of Axon Enterprise by 0.8% during the first quarter. Avantax Advisory Services Inc. now owns 5,302 shares of the biotechnology company’s stock valued at $1,659,000 after buying an additional 40 shares during the last quarter. Brookstone Capital Management boosted its position in Axon Enterprise by 5.1% during the 1st quarter. Brookstone Capital Management now owns 839 shares of the biotechnology company’s stock worth $263,000 after acquiring an additional 41 shares during the period. CWM LLC grew its stake in shares of Axon Enterprise by 1.5% in the second quarter. CWM LLC now owns 2,820 shares of the biotechnology company’s stock worth $830,000 after purchasing an additional 43 shares in the last quarter. Wealthspan Partners LLC increased its holdings in shares of Axon Enterprise by 4.9% during the second quarter. Wealthspan Partners LLC now owns 965 shares of the biotechnology company’s stock valued at $284,000 after purchasing an additional 45 shares during the period. Finally, Burns Matteson Capital Management LLC increased its holdings in shares of Axon Enterprise by 6.7% during the second quarter. Burns Matteson Capital Management LLC now owns 730 shares of the biotechnology company’s stock valued at $215,000 after purchasing an additional 46 shares during the period. 79.08% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research firms recently weighed in on AXON. Barclays upped their price objective on shares of Axon Enterprise from $381.00 to $387.00 and gave the stock an “overweight” rating in a report on Wednesday, August 7th. Jefferies Financial Group began coverage on shares of Axon Enterprise in a report on Wednesday, July 17th. They issued a “buy” rating and a $385.00 price objective for the company. Northland Securities raised their price objective on shares of Axon Enterprise from $330.00 to $365.00 and gave the company an “outperform” rating in a research note on Thursday, August 8th. Needham & Company LLC restated a “buy” rating and issued a $400.00 target price on shares of Axon Enterprise in a research report on Wednesday, August 7th. Finally, JMP Securities lifted their price target on Axon Enterprise from $375.00 to $430.00 and gave the company an “outperform” rating in a research report on Thursday, September 12th. Two analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to MarketBeat.com, Axon Enterprise presently has an average rating of “Moderate Buy” and an average target price of $365.38.

View Our Latest Report on AXON

Insider Activity at Axon Enterprise

In other Axon Enterprise news, CFO Brittany Bagley sold 4,338 shares of Axon Enterprise stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $378.95, for a total transaction of $1,643,885.10. Following the transaction, the chief financial officer now directly owns 98,825 shares in the company, valued at approximately $37,449,733.75. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. In other Axon Enterprise news, CFO Brittany Bagley sold 4,338 shares of the firm’s stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $378.95, for a total transaction of $1,643,885.10. Following the completion of the sale, the chief financial officer now directly owns 98,825 shares in the company, valued at approximately $37,449,733.75. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Matthew R. Mcbrady sold 2,000 shares of Axon Enterprise stock in a transaction dated Friday, August 9th. The shares were sold at an average price of $364.66, for a total value of $729,320.00. Following the transaction, the director now directly owns 4,892 shares in the company, valued at approximately $1,783,916.72. The disclosure for this sale can be found here. In the last 90 days, insiders sold 317,981 shares of company stock worth $115,662,734. 6.10% of the stock is owned by corporate insiders.

Axon Enterprise Stock Up 0.9 %

Shares of Axon Enterprise stock opened at $393.29 on Monday. Axon Enterprise, Inc. has a 12-month low of $189.12 and a 12-month high of $393.58. The firm has a market capitalization of $29.68 billion, a PE ratio of 115.00, a price-to-earnings-growth ratio of 10.34 and a beta of 0.94. The company has a quick ratio of 2.52, a current ratio of 2.88 and a debt-to-equity ratio of 0.35. The stock’s fifty day moving average is $348.04 and its 200-day moving average is $317.24.

Axon Enterprise (NASDAQ:AXONGet Free Report) last posted its quarterly earnings data on Tuesday, August 6th. The biotechnology company reported $1.20 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.02 by $0.18. Axon Enterprise had a return on equity of 9.34% and a net margin of 16.06%. The firm had revenue of $504.00 million for the quarter, compared to the consensus estimate of $478.35 million. During the same quarter in the previous year, the company earned $0.80 EPS. The business’s revenue for the quarter was up 34.5% compared to the same quarter last year. Equities analysts anticipate that Axon Enterprise, Inc. will post 1.79 earnings per share for the current year.

About Axon Enterprise

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

See Also

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXONFree Report).

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.